Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium adenocarcinoma, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder	Not yet recruiting	Phase 2	2024-01-23		NCT06066216

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fujian Cancer Hospital	114
Fujian Provincial Hospital	45
The First Affiliated Hospital of Bengbu Medical University	47
The First Affiliated Hospital of Nanchang University	84
Zhangzhou Affiliated Hospital of Fujian Medical University	11

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.